Find your next paid study

Vanderbilt University Medical CenterNCT04074356

Actual pay is set by the research site.

Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients in Gout (Pharm-UP) Study

This study will compare two different approaches to manage medications that lower uric acid levels. This study will be conducted at five VA medical centers acr…

GoutGouty Arthritis

VA Office of Research and DevelopmentNCT06887452

~$10 – $675

Actual pay is set by the research site.

Rotator Cuff DiseaseSubacromial Pain SyndromeShoulder Pain+1 more

Functional Electrical Stimulation for Improving Shoulder Pain

The goal of this clinical trial is to learn whether adding functional electrical stimulation (FES) to a shoulder exercise program improves how the shoulder mus…

~$10 – $1,125

Actual pay is set by the research site.

Lisa GriffinNCT07886827

Psychological DistressPsychological Well-being

Two Sessions of Coach-Delivered Core Transformation for Psychological Distress and Well-Being in Community Adults: A Randomized Waitlist-Controlled Trial

The goal of this study is to learn if Core Transformation, a guided coaching process, lowers psychological distress in adults. It will also look at well-being,…

Andreas NLP (Legal Entity - Real People Press)NCT07879196

~$10 – $1,125

Actual pay is set by the research site.

Phase 2

A Phase 2 Randomized, Double-blind Placebo-Controlled Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety and Efficacy of WIN378 in Adult Participants With Moderate or Severe Asthma

This is a global Phase 2 study divided in two parts. Part A is a double-blind, randomized dose-range finding study in adults with moderate to severe asthma to …

Asthma

Lung CancerLung Cancer Stage ILung Cancer Stage II

~$75 – $3,000

Actual pay is set by the research site.

Windward BioNCT07120503

Phase 2

Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®

This is a feasibility study to determine the usefulness of a brachytherapy device that utilizes active components (palladium-103) of standard devices in a nove…

CivaTech OncologyNCT03290534

~$75 – $3,000

Actual pay is set by the research site.

Quality of Pediatric Resuscitation in a Multicenter Collaborative: An Observational Study

This is a prospective, observational, multi-center cohort study of pediatric cardiac arrests. The purpose of the study is to determine the association between…

Cardiac ArrestCardiopulmonary Arrest

Children's Hospital of PhiladelphiaNCT02708134

Actual pay is set by the research site.

PrediabetesType 2 Diabetes

Targeted Upstream Prevention (T-UP): Engaging Vulnerable Students in Diabetes Prevention

The goal of this study is to enhance reach and uptake of diabetes prevention among young adults, with a focus on recruiting underserved and high-need students …

University of California, Los AngelesNCT07225218

Actual pay is set by the research site.

Helpline Delivery of Brief Interventions for Postpartum Heavy Episodic Drinking

The pilot factorial trial will (1) evaluate feasibility, acceptability, and fidelity of the intervention components (Aim 2.1), and (2) collect proof-of-concept…

Heavy Drinking

The National Center on Addiction and Substance Abuse at Columbia UniversityNCT06591026

Actual pay is set by the research site.

Phase 3

A Phase III, Multicentre, Randomised, Open-label Study to Compare the Efficacy and Safety of AZD0486 Plus Rituximab Versus Chemotherapy Plus Rituximab in Previously Untreated Participants With Follicular Lymphoma (SOUNDTRACK-F1)

This is a global, randomised, Phase III, multicentre, open-label study evaluating the efficacy, safety and the degree of added benefit of the Surovatamig (AZD0…

Untreated Follicular Lymphoma

~$50 – $2,250

Actual pay is set by the research site.

AstraZenecaNCT06549595

Phase 1

A Two-Part Open-Label Study of REGV131-LNP1265, A CRISPR/Cas9 Based Coagulation Factor IX Gene Insertion Therapy in Participants With Hemophilia B

Participants in this study have a genetic mutation, specifically in the coagulation (blood clotting) Factor 9 gene that causes severe or moderately severe hemo…

Hemophilia B

Regeneron PharmaceuticalsNCT06379789

~$150 – $4,200

Actual pay is set by the research site.

Phase 3

A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Phase 3, Induction Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study, comprised of 3 sub-studies, to evaluate the effica…

Crohn's Disease